Basics Cassava Sciences, Inc. IPO Date: July 14, 2000 Sector: Healthcare Industry: Pharma Market Cap: $99.51M Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 4.33% Avg Daily Range (30 D): $0.07 | 3.17% Avg Daily Range (90 D): $0.06 | 3.35% Institutional Daily Volume Avg Daily Volume: 2.58M Avg Daily Volume (30 D): .82M Avg Daily Volume (90 D): 1.16M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 192 Avg Trade Size (Sh.) (90 D): 213 Institutional Trades Total Inst.Trades: 2,709 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $2.46M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $6.01M Avg Closing Trade (90 D): $3.34M Avg Closing Volume: 74.19K     News Mar 3, 2025 @ 6:00 PM LEQEMBI Market Sales Reflect Growing Confidence in... Source: Delveinsight Feb 8, 2025 @ 4:19 PM SAVA Deadline in 2 Days: Kessler Topaz Meltzer & C... Source: N/A Feb 6, 2025 @ 6:49 PM The Gross Law Firm Announces the Filing of a Secur... Source: The Gross Law Firm Feb 6, 2025 @ 3:03 AM CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER RE... Source: Claimsfiler Feb 5, 2025 @ 9:00 PM SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.48 $-.58 $.13 Diluted EPS $-.48 $-.58 $.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -23.4M $ -27.94M $ 6.16M Operating Income / Loss $ -24.59M $ -30.62M $ -61.4M Cost of Revenue $ $ $ Net Cash Flow $ M $ -18.31M $ 86.16M PE Ratio     Splits Dec 21, 2023:   14:10 May 10, 2017:   1:7